| Dr Yimar Berrios-diaz, | |
|
Carr 165 Km 1.2 #48, City Plaza Suite 1010, Guaynabo, PR 00968 | |
| (787) 250-1708 | |
| (787) 758-9200 |
| Full Name | Dr Yimar Berrios-diaz |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 18 Years |
| Location | Carr 165 Km 1.2 #48, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760795702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 257381-1 (New York) | Secondary |
| 207L00000X | Anesthesiology | 18554 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rcp Anesthesia Psc | 5395829428 | 3 |
News Archive
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5450(a)(1).
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
During the four years of medical school training, students can either study, sleep or have a social life, but never all three, joked Joel Rosenfeld, MD, M.Ed, FACS, Chief Academic Officer, St. Luke's University Health Network, and Senior Associate Dean, Lewis Katz School of Medicine at Temple University.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.
› Verified 2 days ago
| Entity Name | Rcp Anesthesia Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023115433 PECOS PAC ID: 5395829428 Enrollment ID: O20080227000449 |
News Archive
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5450(a)(1).
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
During the four years of medical school training, students can either study, sleep or have a social life, but never all three, joked Joel Rosenfeld, MD, M.Ed, FACS, Chief Academic Officer, St. Luke's University Health Network, and Senior Associate Dean, Lewis Katz School of Medicine at Temple University.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yimar Berrios-diaz, Po Box 366257, San Juan, PR 00936-6257 Ph: (787) 250-1708 | Dr Yimar Berrios-diaz, Carr 165 Km 1.2 #48, City Plaza Suite 1010, Guaynabo, PR 00968 Ph: (787) 250-1708 |
News Archive
A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on September 15, 2009, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5450(a)(1).
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
During the four years of medical school training, students can either study, sleep or have a social life, but never all three, joked Joel Rosenfeld, MD, M.Ed, FACS, Chief Academic Officer, St. Luke's University Health Network, and Senior Associate Dean, Lewis Katz School of Medicine at Temple University.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.
› Verified 2 days ago
Jimena Marino-nieto, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 21c Cond Santa Ana, Guaynabo, PR 00966 Phone: 787-480-2791 | |
Dr. Jeannette Maldonado Carrero, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Carr 165 Km 1.2 # 48, City View Plaza Suite 1010, Guaynabo, PR 00968 Phone: 787-250-1708 Fax: 787-758-9200 | |
Dr. Eloy Ruiz-pagan, Anesthesiology Medicare: Medicare Enrolled Practice Location: 101 Ave Ortegon, Apt. 1703, Guaynabo, PR 00966 Phone: 787-783-9277 Fax: 787-792-3831 | |
Ricardo Galan, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Urb Santa Paula Las Colinas 42, Guaynabo, PR 00969 Phone: 787-373-9598 |